{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T13:31:38Z","timestamp":1794231098518,"version":"4.9.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["R34 #1R34MH108437-01A1"],"award-info":[{"award-number":["R34 #1R34MH108437-01A1"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["P30AI045008"],"award-info":[{"award-number":["P30AI045008"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Sex Behav"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10508-026-03524-z","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:30:16Z","timestamp":1790785816000},"page":"3273-3286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Just4Us: Acceptability and Feasibility of a Woman-Focused Pre-exposure Prophylaxis (PrEP) Randomized Controlled Trial Intervention"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7880-6448","authenticated-orcid":false,"given":"Hong-Van","family":"Tieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beryl","family":"Koblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annet","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Teitelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Just4Us Study Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"issue":"13","key":"3524_CR1","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa2407001","volume":"391","author":"L-G Bekker","year":"2024","unstructured":"Bekker, L.-G., Das, M., Abdool Karim, Q., Ahmed, K., Batting, J., Brumskine, W., Gill, K., Harkoo, I., Jaggernath, M., Kigozi, G., Kiwanuka, N., Kotze, P., Lebina, L., Louw, C. E., Malahleha, M., Manentsa, M., Mansoor, L. E., Moodley, D., Naicker, V., \u2026 PURPOSE 1 Study Team. (2024). Twice-yearly lenacapavir or daily F\/TAF for HIV prevention in cisgender women. New England Journal of Medicine, 391(13), 1179\u20131192. https:\/\/doi.org\/10.1056\/NEJMoa2407001","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"3524_CR2","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s10461-020-02979-y","volume":"25","author":"OJ Blackstock","year":"2021","unstructured":"Blackstock, O. J., Platt, J., Golub, S. A., Anakaraonye, A. R., Norton, B. L., Walters, S. M., Sevelius, J. M., & Cunningham, C. O. (2021). A pilot study to evaluate a novel pre-exposure prophylaxis peer outreach and navigation intervention for women at high risk for HIV infection. AIDS and Behavior, 25(5), 1411\u20131422. https:\/\/doi.org\/10.1007\/s10461-020-02979-y","journal-title":"AIDS and Behavior"},{"issue":"1","key":"3524_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/QAI.0000000000003312","volume":"95","author":"K Bunge","year":"2024","unstructured":"Bunge, K., Balkus, J. E., Fairlie, L., Mayo, A. J., Nakabiito, C., Mgodi, N., Gadama, L., Matrimbira, M., Chappell, C. A., Piper, J., Chakhtoura, N., Szydlo, D. W., Richardson, B., & Hillier, S. L. (2024). DELIVER: A safety study of a dapivirine vaginal ring and oral PrEP for the prevention of HIV during pregnancy. Journal of Acquired Immune Deficiency Syndromes, 95(1), 65\u201373. https:\/\/doi.org\/10.1097\/QAI.0000000000003312","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"3524_CR4","unstructured":"CDC. (2024, May 14). Expanding PrEP coverage in the United States to achieve EHE goals. National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention. https:\/\/www.cdc.gov\/nchhstp\/director-letters\/expanding-prep-coverage.html"},{"key":"3524_CR5","unstructured":"CDC. (2026, March 5). Estimated HIV incidence and prevalence. HIV Data. https:\/\/www.cdc.gov\/hiv-data\/nhss\/estimated-hiv-incidence-and-prevalence.html"},{"key":"3524_CR6","unstructured":"Centers for Disease Control and Prevention: US Public Health Service. (2021, December 1). Preexposure prophylaxis for the prevention of HIV infection in the United States \u2013 2021 update: A clinical practice guideline. https:\/\/stacks.cdc.gov"},{"issue":"4","key":"3524_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11904-024-00700-5","volume":"21","author":"C Chandra","year":"2024","unstructured":"Chandra, C., Hudson, A. F., Alohan, D. I., Young, H. N., & Crawford, N. D. (2024). Implementation science of integrating pre-exposure prophylaxis in pharmacist-led services in the United States. Current HIV\/AIDS Reports, 21(4), 197\u2013207. https:\/\/doi.org\/10.1007\/s11904-024-00700-5","journal-title":"Current HIV\/AIDS Reports"},{"key":"3524_CR8","unstructured":"Charmaz, K. (2014). Constructing grounded theory (2nd ed.). Sage Publications."},{"issue":"2","key":"3524_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1037\/sah0000194","volume":"5","author":"D Chittamuru","year":"2020","unstructured":"Chittamuru, D., Frye, V., Koblin, B. A., Brawner, B., Tieu, H.-V., Davis, A., & Teitelman, A. (2020). PrEP stigma, HIV stigma, and intention to use PrEP among women in New York City and Philadelphia. Stigma and Health, 5(2), 240\u2013246. https:\/\/doi.org\/10.1037\/sah0000194","journal-title":"Stigma and Health"},{"issue":"10337","key":"3524_CR10","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0140-6736(22)00538-4","volume":"399","author":"S Delany-Moretlwe","year":"2022","unstructured":"Delany-Moretlwe, S., Hughes, J. P., Bock, P., Ouma, S. G., Hunidzarira, P., Kalonji, D., Kayange, N., Makhema, J., Mandima, P., Mathew, C., Spooner, E., Mpendo, J., Mukwekwerere, P., Mgodi, N., Ntege, P. N., Nair, G., Nakabiito, C., Nuwagaba-Biribonwoha, H., Panchia, R., \u2026 HPTN 084 Study Group. (2022). Cabotegravir for the prevention of HIV-1 in women: Results from HPTN 084, a phase 3, randomised clinical trial. Lancet, 399(10337), 1779\u20131789. https:\/\/doi.org\/10.1016\/S0140-6736(22)00538-4","journal-title":"Lancet"},{"issue":"14","key":"3524_CR11","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1001\/jama.252.14.1905","volume":"252","author":"JA Ewing","year":"1984","unstructured":"Ewing, J. A. (1984). Detecting alcoholism. The CAGE questionnaire. JAMA, 252(14), 1905\u20131907. https:\/\/doi.org\/10.1001\/jama.252.14.1905","journal-title":"JAMA"},{"key":"3524_CR12","unstructured":"FDA. (2024, August 9). FDA approves first injectable treatment for HIV pre-exposure prevention. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention"},{"issue":"2","key":"3524_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11904-018-0385-0","volume":"15","author":"SA Golub","year":"2018","unstructured":"Golub, S. A. (2018). PrEP stigma: Implicit and explicit drivers of disparity. Current HIV\/AIDS Reports, 15(2), 190\u2013197. https:\/\/doi.org\/10.1007\/s11904-018-0385-0","journal-title":"Current HIV\/AIDS Reports"},{"issue":"5","key":"3524_CR14","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1080\/13691058.2021.1877824","volume":"24","author":"GY Jackson","year":"2022","unstructured":"Jackson, G. Y., Darlington, C. K., Van Tieu, H., Brawner, B. M., Flores, D. D., Bannon, J. A., Davis, A., Frye, V., Chittamuru, D., Gugerty, P., Koblin, B. A., & Teitelman, A. M. (2022). Women\u2019s views on communication with health care providers about pre-exposure prophylaxis (PrEP) for HIV prevention. Culture, Health & Sexuality, 24(5), 642\u2013656. https:\/\/doi.org\/10.1080\/13691058.2021.1877824","journal-title":"Culture, Health & Sexuality"},{"issue":"3","key":"3524_CR16","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1016\/S2352-3018(21)00280-0","volume":"9","author":"DL Joseph Davey","year":"2022","unstructured":"Joseph Davey, D. L., Bekker, L.-G., Bukusi, E. A., Chi, B. H., Delany-Moretlwe, S., Goga, A., Lyerly, A. D., Mgodi, N. M., Mugo, N., Myer, L., Noguchi, L. M., Stranix-Chibanda, L., Slack, C., & Pintye, J. (2022). Where are the pregnant and breastfeeding women in new pre-exposure prophylaxis trials? The imperative to overcome the evidence gap. The Lancet. HIV, 9(3), e214\u2013e222. https:\/\/doi.org\/10.1016\/S2352-3018(21)00280-0","journal-title":"The Lancet. HIV"},{"issue":"1","key":"3524_CR15","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/S2352-3018(19)30371-6","volume":"7","author":"D Joseph Davey","year":"2020","unstructured":"Joseph Davey, D., Myer, L., & Coates, T. (2020). PrEP implementation in pregnant and post-partum women. The Lancet. HIV, 7(1), e5\u2013e6. https:\/\/doi.org\/10.1016\/S2352-3018(19)30371-6","journal-title":"The Lancet. HIV"},{"issue":"1","key":"3524_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1089\/jwh.2019.8217","volume":"30","author":"HR O\u2019Connell","year":"2021","unstructured":"O\u2019Connell, H. R., & Criniti, S. M. (2021). The impact of HIV pre-exposure prophylaxis (PrEP) counseling on PrEP knowledge and attitudes among women seeking family planning care. Journal of Women\u2019s Health, 30(1), 121\u2013130. https:\/\/doi.org\/10.1089\/jwh.2019.8217","journal-title":"Journal of Women\u2019s Health"},{"key":"3524_CR18","unstructured":"Office of Infectious Disease and HIV\/AIDS Policy, HHS. (2026). Ending the HIV epidemic. HIV.Gov. https:\/\/www.hiv.gov\/federal-response\/ending-the-hiv-epidemic\/overview"},{"key":"3524_CR19","unstructured":"Pew Research Center. (2025, November 20). Demographics of mobile device ownership and adoption in the United States. Pew Research Center. https:\/\/www.pewresearch.org\/internet\/fact-sheet\/mobile\/"},{"issue":"1","key":"3524_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/QAI.0000000000001879","volume":"80","author":"JR Raifman","year":"2019","unstructured":"Raifman, J. R., Schwartz, S. R., Sosnowy, C. D., Montgomery, M. C., Almonte, A., Bazzi, A. R., Drainoni, M.-L., Stein, M. D., Willie, T. C., Nunn, A. S., & Chan, P. A. (2019). Pre-exposure prophylaxis awareness and use among cisgender women at a sexually transmitted disease clinic. Journal of Acquired Immune Deficiency Syndromes, 80(1), 36\u201339. https:\/\/doi.org\/10.1097\/QAI.0000000000001879","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"3","key":"3524_CR21","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1097\/QAI.0000000000002558","volume":"86","author":"AM Roth","year":"2021","unstructured":"Roth, A. M., Tran, N. K., Felsher, M., Gadegbeku, A. B., Piecara, B., Fox, R., Krakower, D. S., Bellamy, S. L., Amico, K. R., Benitez, J. A., & Van Der Pol, B. (2021). Integrating HIV preexposure prophylaxis with community-based syringe services for women who inject drugs: Results from the Project SHE Demonstration Study. Journal of Acquired Immune Deficiency Syndromes, 86(3), e61\u2013e70. https:\/\/doi.org\/10.1097\/QAI.0000000000002558","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"6","key":"3524_CR22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.ijnss.2025.10.006","volume":"12","author":"Y Sitthimongkol","year":"2025","unstructured":"Sitthimongkol, Y., Srimoragot, M., Kasemsuk, W., Meekusol, S., Pongpattanapisit, P., Saenkla, P., & Ruksakulpiwat, S. (2025). Enhancing accessibility through nurse-led clinics in primary care: An integrative review of models of care. International Journal of Nursing Sciences, 12(6), 593\u2013600. https:\/\/doi.org\/10.1016\/j.ijnss.2025.10.006","journal-title":"International Journal of Nursing Sciences"},{"issue":"2","key":"3524_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/JNC.0000000000000233","volume":"32","author":"AM Teitelman","year":"2021","unstructured":"Teitelman, A. M., Koblin, B. A., Brawner, B. M., Davis, A., Darlington, C., Lipsky, R. K., Iwu, E., Bond, K. T., Westover, J., Fiore, D., & Tieu, H.-V. (2021). Just4Us: Development of a counselor-navigator and text message intervention to promote PrEP uptake among cisgender women at elevated risk for HIV. Journal of the Association of Nurses in AIDS Care: JANAC, 32(2), 188\u2013204. https:\/\/doi.org\/10.1097\/JNC.0000000000000233","journal-title":"Journal of the Association of Nurses in AIDS Care: JANAC"},{"issue":"3","key":"3524_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/09540121.2021.1894319","volume":"34","author":"AM Teitelman","year":"2022","unstructured":"Teitelman, A. M., Tieu, H.-V., Flores, D., Bannon, J., Brawner, B. M., Davis, A., Gugerty, P., & Koblin, B. (2022). Individual, social and structural factors influencing PrEP uptake among cisgender women: A theory-informed elicitation study. AIDS Care, 34(3), 273\u2013283. https:\/\/doi.org\/10.1080\/09540121.2021.1894319","journal-title":"AIDS Care"},{"issue":"9","key":"3524_CR25","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1007\/s10461-023-04017-z","volume":"27","author":"AM Teitelman","year":"2023","unstructured":"Teitelman, A. M., Tieu, H.-V., Chittamuru, D., Shaw, P. A., Nandi, V., Davis, A., Lipsky, R. K., Darlington, C. K., Fiore, D., & Koblin, B. A. (2023). A randomized controlled pilot study of Just4Us, a counseling and navigation intervention to promote oral HIV prophylaxis uptake among PrEP-eligible cisgender women. AIDS and Behavior, 27(9), 2944\u20132958. https:\/\/doi.org\/10.1007\/s10461-023-04017-z","journal-title":"AIDS and Behavior"},{"issue":"4","key":"3524_CR26","doi-asserted-by":"publisher","first-page":"423.e1","DOI":"10.1016\/j.ajog.2023.07.046","volume":"229","author":"R Wang","year":"2023","unstructured":"Wang, R., Fruhauf, T. F., Sao, S. S., Gingher, E. L., Martin, S. J., & Coleman, J. S. (2023). Clinic-based interventions to increase preexposure prophylaxis awareness and uptake among United States patients attending an obstetrics and gynecology clinic in Baltimore, Maryland. American Journal of Obstetrics and Gynecology, 229(4), 423.e1-423.e8. https:\/\/doi.org\/10.1016\/j.ajog.2023.07.046","journal-title":"American Journal of Obstetrics and Gynecology"}],"container-title":["Archives of Sexual Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10508-026-03524-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10508-026-03524-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10508-026-03524-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T13:16:08Z","timestamp":1794230168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10508-026-03524-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3524"],"URL":"https:\/\/doi.org\/10.1007\/s10508-026-03524-z","relation":{},"ISSN":["0004-0002","1573-2800"],"issn-type":[{"value":"0004-0002","type":"print"},{"value":"1573-2800","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received Institutional Review Board approval at the New York Blood Center and the University of Pennsylvania.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}